IP Verse

Momenta Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Momenta Pharmaceuticals opposed by its competitors

Explore Momenta Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2968549
Nov 23, 2022Methods Of Cell Culture2
EP2971040
Sep 19, 2018Methods Of Cell Culture10

Latest publications and patents of Momenta Pharmaceuticals New

Explore the latest publications and patents granted to Momenta Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Momenta Pharmaceuticals

EP2968549
Nov 23, 2022Methods Of Cell CulturePatent Maintained As Amended
EP2971040
Sep 19, 2018Methods Of Cell CultureRevoked

Latest PTAB cases involving Momenta Pharmaceuticals

Discover the latest PTAB cases involving Momenta Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 25, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Momenta Pharmaceuticals

IPR2015-01537Jul 2, 2015MOMENTA PHARMACEUTICALSBRISTOL MYERS SQUIBBFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Momenta Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MOMENTA PHARMACEUTICALS - 121 -
BAYER3156 - -
DORRIES9 - - -
REGENERON PHARMACEUTICALS3894931